Articles dans des revues avec comité de lecture (237)
  1. 9. El Oumeiri, B. G., Van De Borne, P., Hubesch, G., Jespers, P., Dewachter, L., Stefanidis, C., McEntee, K., & Vanden Eynden, F. (2022). Detection of soluble suppression of tumorigenicity 2 and N-terminal B-type natriuretic peptide in a rat model of aortic regurgitation: differential responses to omecamtiv mecarbil. Journal of basic & clinical physiology & pharmacology, 33(6), 743-750. doi:10.1515/jbcpp-2022-0215
  2. 10. Lavis, P., Morra, S., Orte Cano, C., Albayrak, N., Corbiere, V., Olislagers, V., Dauby, N., Del Marmol, V., Marchant, A., Decaestecker, C., Mascart, F., De Vos, N., Van De Borne, P., Salmon, I., Remmelink, M., Parmentier, M., Cardozo, A. K., & Bondue, B. (2022). Chemerin plasma levels are increased in COVID-19 patients and are an independent risk factor of mortality. Frontiers in immunology, 13, 941663. doi:10.3389/fimmu.2022.941663
  3. 11. Douin, C., Forton, K., Lamotte, M., Gillet, A., & Van De Borne, P. (2022). Benefits of Cardio-Pulmonary Rehabilitation in Moderate to Severe Forms of COVID-19 Infection. Healthcare (Switzerland), 10(10), 2044. doi:10.3390/healthcare10102044
  4. 12. Gillet, A., Chaumont, M., Lamotte, M., Roussoulieres, A., Dewachter, C., Forton, K., Deboeck, G., & Van De Borne, P. (2022). EFFORT PERCEPTION AND HEMODYNAMIC RESPONSES TO THE 3/7 VS. 3X9 METHODS IN HEART FAILURE AND IN CORONARY ARTERY DISEASE PATIENTS: A RANDOMIZED-CROSS-OVER STUDY. Journal of hypertension, 40(Suppl 1), e295. doi:10.1097/01.hjh.0000838588.28000.dd
  5. 13. Gillet, A., Lamotte, M., Forton, K., Roussoulieres, A., Dewachter, C., Deboeck, G., & Van De Borne, P. (2022). Effort perception and hemodynamic responses to the 3/7 vs. 3X9 methods in heart failure and in coronary artery disease patients: a randomized-cross-over study. European journal of preventive cardiology, 29(Supplement_1). doi:10.1093/eurjpc/zwac056.243
  6. 14. Borghi, C., Ambrosio, G., Van De Borne, P., & Mancia, G. (2022). Zofenopril: Blood pressure control and cardio-protection. Cardiology Journal, 29(2), 305-318. doi:10.5603/CJ.a2021.0113
  7. 15. Loas, G., Van De Borne, P., Darquennes, G., & Le Corre, P. (2022). Association of Amlodipine with the Risk of In-Hospital Death in Patients with COVID-19 and Hypertension: A Reanalysis on 184 COVID-19 Patients with Hypertension. Pharmaceuticals, 15(3), 380. doi:10.3390/ph15030380
  8. 16. Rabineau, J., Nonclercq, A., Leiner, T., Van De Borne, P., Migeotte, P.-F., & Haut, B. (2021). Closed-Loop Multiscale Computational Model of Human Blood Circulation. Applications to Ballistocardiography. Frontiers in physiology, 12, 734311.
  9. 17. Khadir, K., Mirica, D. C., Ligot, N., & Van De Borne, P. (2021). Can chronic anti-tumour necrosing factor therapy and colic polyps overwhelm a normal functioning mitral valve? A case report of an endocarditis complicated by a ruptured intracranial mycotic aneurysm. European Heart Journal - Case Reports, 5(12). doi:10.1093/ehjcr/ytab515
  10. 18. De Becker, B., Hupkens, E., Dewachter, L., Coremans, C., Delporte, C., Van Antwerpen, P., Franck, T., Zouaoui Boudjeltia, K., Cullus, P., & Van De Borne, P. (2021). Acute effects of hypouricemia on endothelium, oxidative stress, and arterial stiffness: A randomized, double‐blind, crossover study. Physiological Reports, 9(17). doi:10.14814/phy2.15018
  11. 19. El Oumeiri, B. G., Van De Borne, P., Hubesch, G., Herpain, A., Annoni, F., Jespers, P., Stefanidis, C., Mc Entee, K., & Vanden Eynden, F. (2021). The myosin activator omecamtiv mecarbil improves wall stress in a rat model of chronic aortic regurgitation. Physiological Reports, 9(16), e14988. doi:10.14814/phy2.14988
  12. 20. Coremans, C., Delporte, C., Cotton, F., Van De Borne, P., Zouaoui Boudjeltia, K., & Van Antwerpen, P. (2021). Mass Spectrometry for the Monitoring of Lipoprotein Oxidations by Myeloperoxidase in Cardiovascular Diseases. Molecules, 26(17). doi:10.3390/molecules26175264
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Suivant >>